NCT06484907View on ClinicalTrials.gov

Predicting CSA-AKI With ACTA-PORT Score

CompletedOBSERVATIONAL
Enrollment

467

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

September 15, 2024

Study Completion Date

December 1, 2024

Conditions
Cardiac DiseaseBlood TransfusionAcute Kidney Injury
Trial Locations (1)

06800

Ankara Bilkent City Hospital, Ankara

All Listed Sponsors
lead

Ankara City Hospital Bilkent

OTHER

NCT06484907 - Predicting CSA-AKI With ACTA-PORT Score | Biotech Hunter | Biotech Hunter